Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs PLETHICO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN PLETHICO PHARMA LUPIN/
PLETHICO PHARMA
 
P/E (TTM) x 40.7 -0.1 - View Chart
P/BV x 6.0 0.0 35,715.7% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 LUPIN   PLETHICO PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-23
PLETHICO PHARMA
Mar-14
LUPIN/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs799254 314.5%   
Low Rs58331 1,865.8%   
Sales per share (Unadj.) Rs365.8604.6 60.5%  
Earnings per share (Unadj.) Rs9.832.5 30.3%  
Cash flow per share (Unadj.) Rs29.251.3 56.9%  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs270.7473.7 57.1%  
Shares outstanding (eoy) m454.9834.07 1,335.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.90.2 800.9%   
Avg P/E ratio x70.24.4 1,599.7%  
P/CF ratio (eoy) x23.72.8 852.0%  
Price / Book Value ratio x2.60.3 847.9%  
Dividend payout %40.70-   
Avg Mkt Cap Rs m314,3814,859 6,470.4%   
No. of employees `000NANA-   
Total wages/salary Rs m30,8721,547 1,995.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,41720,598 807.9%  
Other income Rs m1,509419 359.8%   
Total revenues Rs m167,92621,017 799.0%   
Gross profit Rs m17,2062,938 585.6%  
Depreciation Rs m8,807642 1,371.2%   
Interest Rs m2,7431,747 157.0%   
Profit before tax Rs m7,165968 739.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,688-138 -1,942.3%   
Profit after tax Rs m4,4771,107 404.5%  
Gross profit margin %10.314.3 72.5%  
Effective tax rate %37.5-14.3 -262.5%   
Net profit margin %2.75.4 50.1%  
BALANCE SHEET DATA
Current assets Rs m124,51318,877 659.6%   
Current liabilities Rs m92,65411,896 778.8%   
Net working cap to sales %19.133.9 56.5%  
Current ratio x1.31.6 84.7%  
Inventory Days Days2678 33.6%  
Debtors Days Days98198 49.7%  
Net fixed assets Rs m103,49014,269 725.3%   
Share capital Rs m910341 267.1%   
"Free" reserves Rs m122,24615,798 773.8%   
Net worth Rs m123,15616,139 763.1%   
Long term debt Rs m2754,706 5.8%   
Total assets Rs m228,00333,146 687.9%  
Interest coverage x3.61.6 232.4%   
Debt to equity ratio x00.3 0.8%  
Sales to assets ratio x0.70.6 117.5%   
Return on assets %3.28.6 36.8%  
Return on equity %3.66.9 53.0%  
Return on capital %8.013.0 61.6%  
Exports to sales %021.4 0.0%   
Imports to sales %015.2 0.0%   
Exports (fob) Rs mNA4,402 0.0%   
Imports (cif) Rs mNA3,136 0.0%   
Fx inflow Rs m48,0574,402 1,091.6%   
Fx outflow Rs m21,7523,184 683.2%   
Net fx Rs m26,3061,219 2,158.8%   
CASH FLOW
From Operations Rs m18,9722,437 778.4%  
From Investments Rs m-12,868-6,265 205.4%  
From Financial Activity Rs m-3,3732,490 -135.4%  
Net Cashflow Rs m2,73224 11,160.9%  

Share Holding

Indian Promoters % 46.8 57.8 81.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 45.8 19.4 236.2%  
FIIs % 16.1 2.7 596.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 42.3 125.3%  
Shareholders   281,542 16,430 1,713.6%  
Pledged promoter(s) holding % 0.0 85.7 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs PLETHICO PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs PLETHICO PHARMA Share Price Performance

Period Lupin PLETHICO PHARMA S&P BSE HEALTHCARE
1-Day 1.23% -4.91% 1.18%
1-Month 0.15% -1.24% -0.75%
1-Year 151.14% -70.21% 61.82%
3-Year CAGR 17.13% -66.86% 18.16%
5-Year CAGR 17.42% -51.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the PLETHICO PHARMA share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of PLETHICO PHARMA the stake stands at 57.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of PLETHICO PHARMA.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

PLETHICO PHARMA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Lupin, and the dividend history of PLETHICO PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.